ITCMDBv1
Clinical TrialID 8492

Clinical Study of Vitamin B5 in Adjuvant Treatment of IBD

NCT05701501

Inflammatory Bowel Diseases

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
8492
Evidence Id
8492
Core Evidence Id
8492
Source Clinical Trial Id
8491
Herb2 Clinical Trial Id
HBCT008491
Nct Id
NCT05701501
Title
Clinical Study of Vitamin B5 in Adjuvant Treatment of IBD
Status
Recruiting
Phase
Study Result
No
Study Condition
Inflammatory Bowel Diseases
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Vitamin B5 Tablets|DRUG: placebo
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Double
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
100
Outcome Measure
Clinical remission rate, To evaluate the improvement effect of clinical remission rate (Mayo score ≤ 2 points and no single sub-score\>1 point; CDAI score\<150) in IBD patients after 12 weeks of oral Vitamin B5 while taking routine treatment., Through study completion, an average of 12 months.
Sponsor Collaborator
Changhai Hospital|The University of Science and Technology of China
Funded By
OTHER
Location
Changhai Hospital, Shanghai, 200433, China
Other Id
VitB5
Start Date
2023-02-01
Primary Completion Date
2024-02-01
Completion Date
2024-02-01
First Posted
2023-01-27
Results First Posted
Last Update Posted
2023-06-15
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05701501
Title Cn
Title En
Clinical Study of Vitamin B5 in Adjuvant Treatment of IBD
Bilingual Status
semi_complete